Page last updated: 2024-10-30

leflunomide and Central Serous Retinopathy

leflunomide has been researched along with Central Serous Retinopathy in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research Excerpts

ExcerptRelevanceReference
" She had a history of rheumatoid arthritis and was prescribed 20 mg leflunomide and 16 mg corticosteroid daily."3.91Atypical Presentation of Choroidal Folds: Steroid-induced Central Serous Chorioretinopathy-like Maculopathy ( Afrashi, F; Çeper, SB; Değirmenci, C; Nalçacı, S, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Değirmenci, C1
Afrashi, F1
Nalçacı, S1
Çeper, SB1

Other Studies

1 other study available for leflunomide and Central Serous Retinopathy

ArticleYear
Atypical Presentation of Choroidal Folds: Steroid-induced Central Serous Chorioretinopathy-like Maculopathy
    Turkish journal of ophthalmology, 2019, 12-31, Volume: 49, Issue:6

    Topics: Aged; Arthritis, Rheumatoid; Central Serous Chorioretinopathy; Choroid Diseases; Drug Therapy, Combi

2019
chemdatabank.com